163 related articles for article (PubMed ID: 32497732)
1. Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal.
Varan C; Anceschi A; Sevli S; Bruni N; Giraudo L; Bilgiç E; Korkusuz P; İskit AB; Trotta F; Bilensoy E
Int J Pharm; 2020 Jul; 585():119485. PubMed ID: 32497732
[TBL] [Abstract][Full Text] [Related]
2. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
[TBL] [Abstract][Full Text] [Related]
4. Sustainable mechanochemical synthesis of β-cyclodextrin polymers by twin screw extrusion.
Rubin Pedrazzo A; Trotta F; Hoti G; Cesano F; Zanetti M
Environ Sci Pollut Res Int; 2022 Jan; 29(1):251-263. PubMed ID: 34424473
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.
Swaminathan S; Pastero L; Serpe L; Trotta F; Vavia P; Aquilano D; Trotta M; Zara G; Cavalli R
Eur J Pharm Biopharm; 2010 Feb; 74(2):193-201. PubMed ID: 19900544
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
Mady FM; Ibrahim SR
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity.
Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G
Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development.
Swaminathan S; Cavalli R; Trotta F
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):579-601. PubMed ID: 26800431
[TBL] [Abstract][Full Text] [Related]
10. Biofunctionalization of β-cyclodextrin nanosponges using cholesterol.
Singh P; Ren X; Guo T; Wu L; Shakya S; He Y; Wang C; Maharjan A; Singh V; Zhang J
Carbohydr Polym; 2018 Jun; 190():23-30. PubMed ID: 29628242
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin-based nanosponges: A critical review.
Sherje AP; Dravyakar BR; Kadam D; Jadhav M
Carbohydr Polym; 2017 Oct; 173():37-49. PubMed ID: 28732878
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
[TBL] [Abstract][Full Text] [Related]
13. Degree of crosslinking in β-cyclodextrin-based nanosponges and their effect on piperine encapsulation.
Guineo-Alvarado J; Quilaqueo M; Hermosilla J; González S; Medina C; Rolleri A; Lim LT; Rubilar M
Food Chem; 2021 Mar; 340():128132. PubMed ID: 33011468
[TBL] [Abstract][Full Text] [Related]
14. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
Gabr MM; Mortada SM; Sallam MA
Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Cyclodextrin Nanosponges.
Caldera F; Tannous M; Cavalli R; Zanetti M; Trotta F
Int J Pharm; 2017 Oct; 531(2):470-479. PubMed ID: 28645630
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin nanosponge as a temoporfin nanocarrier: Balancing between accumulation and penetration in 3D tumor spheroids.
Yakavets I; Guereschi C; Lamy L; Kravchenko I; Lassalle HP; Zorin V; Bezdetnaya L
Eur J Pharm Biopharm; 2020 Sep; 154():33-42. PubMed ID: 32634570
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
Mashaqbeh H; Obaidat R; Al-Shar'i N
Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity.
Gaber DA; Radwan MA; Alzughaibi DA; Alail JA; Aljumah RS; Aloqla RM; Alkhalifah SA; Abdoun SA
Drug Deliv; 2023 Dec; 30(1):2174208. PubMed ID: 36744372
[TBL] [Abstract][Full Text] [Related]
19. Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges.
Rezaei A; Varshosaz J; Fesharaki M; Farhang A; Jafari SM
Int J Nanomedicine; 2019; 14():4589-4599. PubMed ID: 31296988
[No Abstract] [Full Text] [Related]
20. Cyclodextrin Nanosponges: A Revolutionary Drug Delivery Strategy.
Singh S; Sharma K; Sharma H
Pharm Nanotechnol; 2023 Sep; ():. PubMed ID: 37807414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
